A. Kamada

发表

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.

S. Szefler, D. Leung, J. Kam, 1994, The Journal of clinical investigation.

Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma.

S. Szefler, D. Ikle, A. Kamada, 1993, The Journal of allergy and clinical immunology.

EFFECT OF 22 MONTHS OF TREATMENT WITH INHALED CORTICOSTEROIDS AND/OR BETA-2- AGONISTS ON LUNG FUNCTION, AIRWAY RESPONSIVENESS, AND SYMPTOMS IN CHILDREN WITH ASTHMA

A. Kamada, 1994, Pediatrics.

Recruitment of participants in the childhood Asthma Management Program (CAMP). I. Description of methods: Childhood Asthma Management Program Research Group.

Thomas F. Smith, T. F. Smith, C. Rand, 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

Possible Interaction between Ciprofloxacin and Warfarin

A. Kamada, 1990, DICP : the annals of pharmacotherapy.

Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin.

J. Lettieri, R. Polk, J. Toscano, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

How should inhaled glucocorticoids be compared?

S. Szefler, A. Kamada, 1997, The Journal of allergy and clinical immunology.

PULMONARY AND ALLERGY

G. Milavetz, H. Kelly, A. Kamada, 2013 .

Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma.

S. Szefler, D. Leung, J. Spahn, 1994, The Journal of pediatrics.

Zileuton: The First 5-Lipoxygenase Inhibitor for the Treatment of Asthma

S. Wenzel, A. Kamada, 1996, The Annals of pharmacotherapy.

Alternative treatments for asthma: assessing the need.

E. Gelfand, S. Szefler, A. Kamada, 1992, The Journal of asthma : official journal of the Association for the Care of Asthma.

Glucocorticoids and growth in asthmatic children

A. Kamada, S. J. Szefler, 1995, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

The role of theophylline in the treatment of asthma.

S. Szefler, A. Kamada, 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Salmeterol: Its Place in Asthma Management

G. Milavetz, H. Kelly, K. Blake, 1994, The Annals of pharmacotherapy.

TIMING OF PREDNISONE AND ALTERATIONS OF AIRWAYS INFLAMMATION IN NOCTURNAL ASTHMA

A. Kamada, 1994 .

Special considerations in the use of glucocorticoids in children.

J. Spahn, A. Kamada, 1995, Pediatrics in review.

Steroid resistance in asthma: Our current understanding

S. Szefler, D. Leung, A. Kamada, 1992, Pediatric pulmonology.

High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response.

S. Szefler, D. Leung, A. Kamada, 1992, The Journal of allergy and clinical immunology.

The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.

Heather Eliassen, Scott T. Weiss, Babi Hammond, 1999, Controlled clinical trials.

REASSESSING THE THERAPEUTIC RANGE FOR THEOPHYLLINE ON LABORATORY REPORT FORMS: THE IMPORTANCE OF 5-15 µg/mL

A. Kamada, 1995, Pediatrics.

METERED-DOSE INHALER ADHERENCE IN A CLINICAL TRIAL

A. Kamada, 1994, Pediatrics.

Effect of Low‐Dose Troleandomycin on Theophylline Clearance: Implications for Therapeutic Drug Monitoring

S. Szefler, A. Brenner, A. Kamada, 1992, Pharmacotherapy.

IN VIVO AND IN VITRO B2-ADRENERGIC RECEPTOR RESPONSIVENESS IN YOUNG AND ELDERLY ASTHMATICS

A. Kamada, 1994 .

Inhaled glucocorticoid therapy in children: How much is safe?

S. Szefler, A. Kamada, David P. Parks, 1992, Pediatric pulmonology.

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.

E. Israel, J. Drazen, H. Boushey, 1996, American journal of respiratory and critical care medicine.

A Pharmacokinetic Comparison of Two Oral Liquid Glucocorticoid Formulations

M. B. Scott, S. Szefler, John C. Seiner, 1997, Pharmacotherapy.

Pulmonary and Allergy

A. Kamada, Gary Milavetz, 1990 .

Inhaled therapy in infants: Why not nebulize glucocorticoids?

S. Szefler, A. Kamada, 1992, Pediatric pulmonology.

FeNO Variability When Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff

A. Kamada, C. Bushe, R. Hafner, 2019, Respiration.

A COMMUNITY-BASED STUDY OF THE EPIDEMIOLOGY OF ASTHMA. INCIDENCE RATES, 1964 TO 1983

A. Kamada, 1994, Pediatrics.